GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Bodisen Biotech Inc (LSE:BODI) » Definitions » Cash And Cash Equivalents

Bodisen Biotech (LSE:BODI) Cash And Cash Equivalents : £0.10 Mil (As of Jun. 2013)


View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Cash And Cash Equivalents?

Bodisen Biotech's quarterly cash and cash equivalents declined from Sep. 2012 (£0.21 Mil) to Dec. 2012 (£0.18 Mil) but then stayed the same from Dec. 2012 (£0.18 Mil) to Jun. 2013 (£0.10 Mil).

Bodisen Biotech's annual cash and cash equivalents declined from Dec. 2010 (£2.36 Mil) to Dec. 2011 (£0.60 Mil) and declined from Dec. 2011 (£0.60 Mil) to Dec. 2012 (£0.18 Mil).


Bodisen Biotech Cash And Cash Equivalents Historical Data

The historical data trend for Bodisen Biotech's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Cash And Cash Equivalents Chart

Bodisen Biotech Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 2.97 2.36 0.60 0.18

Bodisen Biotech Quarterly Data
Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Jun13
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.26 0.21 0.18 0.10

Bodisen Biotech Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Bodisen Biotech  (LSE:BODI) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Bodisen Biotech Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Bodisen Biotech (LSE:BODI) Business Description

Traded in Other Exchanges
N/A
Address
Bodisen Biotech Inc develops, manufactures and sells organic fertilizers, liquid fertilizers, pesticides and insecticides in China.